Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma
Terminated
- Conditions
- Sarcoma
- Registration Number
- NCT00322855
- Lead Sponsor
- New Mexico Cancer Care Alliance
- Brief Summary
To review the outcome of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005.
- Detailed Description
Chart review of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005 to determine outcome
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.
Exclusion Criteria
- Not Specified
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005 up to one year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chemotherapy response in soft tissue sarcoma patients as studied in NCT00322855?
How does the efficacy of chemotherapy in NCT00322855 compare to standard-of-care treatments for soft tissue sarcoma?
What biomarkers were identified in NCT00322855 to predict patient outcomes in soft tissue sarcoma chemotherapy?
What adverse events were observed in NCT00322855 for soft tissue sarcoma patients undergoing chemotherapy?
Are there combination therapies or targeted agents that could improve outcomes compared to NCT00322855's chemotherapy approach?
Trial Locations
- Locations (1)
University of New Mexico
🇺🇸Albuquerque, New Mexico, United States
University of New Mexico🇺🇸Albuquerque, New Mexico, United States